| Project/Area Number |
23659724
|
|---|
| Research Category |
Grant-in-Aid for Challenging Exploratory Research
|
| Allocation Type | Multi-year Fund |
|---|
| Research Field |
Orthopaedic surgery
|
|---|
| Research Institution | Okayama University |
|---|
Principal Investigator |
OZAKI Toshifumi 岡山大学, 大学院・医歯薬学総合研究科, 教授 (40294459)
|
|---|
| Research Collaborator |
KAWAI Akira 独立行政法人国立がん研究センター, 中央病院, 医長
ITO Tatsuo Memorial Sloan-Kettering Cancer Center, Molecular pathology, researcher
|
|---|
| Project Period (FY) |
2011 – 2012
|
| Project Status |
Completed (Fiscal Year 2012)
|
| Budget Amount *help |
¥3,640,000 (Direct Cost: ¥2,800,000、Indirect Cost: ¥840,000)
Fiscal Year 2012: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
Fiscal Year 2011: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
|
|---|
| Keywords | RUNX2 / PRMTs / 蛋白修飾 / バイオマーカー / 骨肉腫 / Runx2 / アルギニンメチル化 / Runx2蛋白 |
|---|
| Research Abstract |
We examined the interaction between PRMT4 and 5 with RUNX2, is major transcription factor in osteoblast differentiation. We found the post-translational arginine methylation of. Using aRunx2me2 antibody we also disclosed the frequency of Runx2me2s is high at Japanese OS patient of poor prognosis in long term prognosis (p
|
